[The treatment of meningococcemia by preserving immune homeostasis].
A study is presented of the cellular-humoral immunity in patients with typical meningococcemia complicated by infectious-toxic shock. Obtained data evidence significant changes of the cellular-humoral immunity in meningococcemias, especially those accompanied by infectious-toxic shock along with traditional methods the authors propose immunoregulatory and pathogenetic treatment: human immunoglobulin, aminocaproic acid, sodium, ethamsilate or dicinon, thymalin or T-activin, dopamin, rifampycin. The dosage of these drugs should be individual. The indications and efficiency should be controlled immunologically.
Lutsik
B D
BD
D000917:Antibody Formation / Q000276:immunology; D016470:Bacteremia / Q000150:complications / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D006706:Homeostasis / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000276:immunology / Q000628:therapy; D008589:Meningococcal Infections / Q000150:complications / Q000276:immunology / Q000628:therapy*; D011379:Prognosis; D012772:Shock, Septic / Q000209:etiology / Q000276:immunology / Q000628:therapy
Lechenie meningokokkemiĭ s sokhraneniem immunnogo gomeostaza.